The DOI matches its Crossref record; 253 of the 253 references it cites were found in a registry or an index.
Targeting IL-10 Family Cytokines for the Treatment of Human Diseases
Open accessAbstract
Members of the interleukin (IL)-10 family of cytokines play important roles in regulating immune responses during host defense but also in autoimmune disorders, inflammatory diseases, and cancer. Although IL-10 itself primarily acts on leukocytes and has potent immunosuppressive functions, other family members preferentially target nonimmune compartments, such as tissue epithelial cells, where they elicit innate defense mechanisms to control viral, bacterial, and fungal infections, protect tissue integrity, and promote tissue repair and regeneration. As cytokines are prime drug targets, IL-10 family cytokines provide great opportunities for the treatment of autoimmune diseases, tissue damage, and cancer. Yet no therapy in this space has been approved to date. Here, we summarize the diverse biology of the IL-10 family as it relates to human disease and review past and current strategies and challenges to target IL-10 family cytokines for clinical use.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Safety, activity, and immune correlates of anti–PD-1 antibody in cancer
Topalian, S. L., Hodi, F. S., Brahmer, J. R., Gettinger, S. N., Smith, D. C., McDermott, D. F., Powderly, J. D., Carvajal, R. D., Sosman, J. A., Atkins, M. B., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1200690 · Cited by 12,628
Nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer
Borghaei, H., Paz-Ares, L., Horn, L., Spigel, D. R., Steins, M., Ready, N. E., Chow, L. Q., Vokes, E. E., Felip, E., Holgado, E., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1507643 · Cited by 9,335
Banks, P. A., Bollen, T. L., Dervenis, C., Gooszen, H. G., Johnson, C. D., Sarr, M. G., Tsiotos, G. G., & Vege, S. S. (2013) · Gut · doi:10.1136/gutjnl-2012-302779 · Cited by 7,187
Interleukin-10 and the Interleukin-10 Receptor
Moore, K. W., de Waal Malefyt, R., Coffman, R. L., & O'Garra, A. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.683 · Cited by 6,737
Singer, A. J., & Clark, R. A. F. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909023411006 · Cited by 6,106
Pembrolizumab versus Ipilimumab in Advanced Melanoma
Robert, C., Schachter, J., Long, G. V., Arance, A., Grob, J. J., Mortier, L., Daud, A., Carlino, M. S., McNeil, C., Lotem, M., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1503093 · Cited by 5,887
Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma
Motzer, R. J., Escudier, B., McDermott, D. F., George, S., Hammers, H. J., Srinivas, S., Tykodi, S. S., Sosman, J. A., Procopio, G., Plimack, E. R., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1510665 · Cited by 5,807
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
Sharma, P., Hu-Lieskovan, S., Wargo, J. A., & Ribas, A. (2017) · Cell · doi:10.1016/j.cell.2017.01.017 · Cited by 5,588
Elements of cancer immunity and the cancer–immune set point
Chen, D. S., & Mellman, I. (2017) · Nature · doi:10.1038/nature21349 · Cited by 5,352
The future of immune checkpoint therapy
Sharma, P., & Allison, J. P. (2015) · Science · doi:10.1126/science.aaa8172 · Cited by 4,878
Unravelling the pathogenesis of inflammatory bowel disease
Xavier, R. J., & Podolsky, D. K. (2007) · Nature · doi:10.1038/nature06005 · Cited by 4,364
Interleukin-10-deficient mice develop chronic enterocolitis
Kühn, R., Löhler, J., Rennick, D., Rajewsky, K., & Müller, W. (1993) · Cell · doi:10.1016/0092-8674(93)80068-p · Cited by 4,274
Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy
Topalian, S. L., Drake, C. G., & Pardoll, D. M. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.03.001 · Cited by 4,229
Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial
Hanauer, S. B., Feagan, B. G., Lichtenstein, G. R., Mayer, L. F., Schreiber, S., Colombel, J. F., Rachmilewitz, D., Wolf, D. C., Olson, A., Bao, W., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08512-4 · Cited by 4,169
de Waal Malefyt, R., Abrams, J., Bennett, B., Figdor, C. G., & de Vries, J. E. (1991) · The Journal of experimental medicine · doi:10.1084/jem.174.5.1209 · Cited by 3,762 · cited 2×
“…such as tumor necrosis factor α (TNF-α), IL-1β, IL-6, IL-8, granulocyte colony-stimulating factor (G-CSF), and granulocyte macrophage colony-stimulating factor (GM-CSF), as well as chemokines, including MCP1, IL-8, and IP-10 (de Waal-Malefyt et al. 1991a; Fiorentino et al. 1991; Moore et al. 2001).”
BackgroundGenetic variation in IL28B predicts hepatitis C treatment-induced viral clearance
Ge, D., Fellay, J., Thompson, A. J., Simon, J. S., Shianna, K. V., Urban, T. J., Heinzen, E. L., Qiu, P., Bertelsen, A. H., Muir, A. J., et al. (2009) · Nature · doi:10.1038/nature08309 · Cited by 3,514
The regulation of IL-10 production by immune cells
Saraiva, M., & O'Garra, A. (2010) · Nature Reviews Immunology · doi:10.1038/nri2711 · Cited by 3,164
IL-10 inhibits cytokine production by activated macrophages
Fiorentino, D. F., Zlotnik, A., Mosmann, T. R., Howard, M., & O’Garra, A. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.147.11.3815 · Cited by 2,888
Nestle, F. O., Kaplan, D. H., & Barker, J. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0804595 · Cited by 2,786
Fiorentino, D. F., Bond, M. W., & Mosmann, T. R. (1989) · The Journal of experimental medicine · doi:10.1084/jem.170.6.2081 · Cited by 2,733
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
Sandborn, W. J., Feagan, B. G., Rutgeerts, P., Hanauer, S., Colombel, J.-F., Sands, B. E., Lukas, M., Fedorak, R. N., Lee, S., Bressler, B., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1215739 · Cited by 2,719
Wound healing and its impairment in the diabetic foot
Falanga, V. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67700-8 · Cited by 2,639
The global burden of diabetic foot disease
Boulton, A. J., Vileikyte, L., Ragnarson-Tennvall, G., & Apelqvist, J. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67698-2 · Cited by 2,566
Franke, A., McGovern, D. P. B., Barrett, J. C., Wang, K., Radford-Smith, G. L., Ahmad, T., Lees, C. W., Balschun, T., Lee, J., Roberts, R., et al. (2010) · Nature Genetics · doi:10.1038/ng.717 · Cited by 2,520
Ferrara, J. L., Levine, J. E., Reddy, P., & Holler, E. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60237-3 · Cited by 2,464
Liang, S. C., Tan, X.-Y., Luxenberg, D. P., Karim, R., Dunussi-Joannopoulos, K., Collins, M., & Fouser, L. A. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20061308 · Cited by 2,330
Genetic variation in IL28B and spontaneous clearance of hepatitis C virus
Thomas, D. L., Thio, C. L., Martin, M. P., Qi, Y., Ge, D., O’hUigin, C., Kidd, J., Kidd, K., Khakoo, S. I., Alexander, G., et al. (2009) · Nature · doi:10.1038/nature08463 · Cited by 2,150
Tanaka, Y., Nishida, N., Sugiyama, M., Kurosaki, M., Matsuura, K., Sakamoto, N., Nakagawa, M., Korenaga, M., Hino, K., Hige, S., et al. (2009) · Nature Genetics · doi:10.1038/ng.449 · Cited by 2,141
Revisiting STAT3 signalling in cancer: new and unexpected biological functions
Yu, H., Lee, H., Herrmann, A., Buettner, R., & Jove, R. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3818 · Cited by 2,137
de Waal Malefyt, R., Haanen, J., Spits, H., Roncarolo, M. G., te Velde, A., Figdor, C., Johnson, K., Kastelein, R., Yssel, H., & de Vries, J. E. (1991) · The Journal of experimental medicine · doi:10.1084/jem.174.4.915 · Cited by 1,930
Regulation and Functions of the IL-10 Family of Cytokines in Inflammation and Disease
Ouyang, W., Rutz, S., Crellin, N. K., Valdez, P. A., & Hymowitz, S. G. (2011) · Annual Review of Immunology · doi:10.1146/annurev-immunol-031210-101312 · Cited by 1,925
Self-citationInterleukin-22 mediates early host defense against attaching and effacing bacterial pathogens
Zheng, Y., Valdez, P. A., Danilenko, D. M., Hu, Y., Sa, S. M., Gong, Q., Abbas, A. R., Modrusan, Z., Ghilardi, N., de Sauvage, F. J., et al. (2008) · Nature Medicine · doi:10.1038/nm1720 · Cited by 1,921
Self-citationIFN-λs mediate antiviral protection through a distinct class II cytokine receptor complex
Kotenko, S. V., Gallagher, G., Baurin, V. V., Lewis-Antes, A., Shen, M., Shah, N. K., Langer, J. A., Sheikh, F., Dickensheets, H., & Donnelly, R. P. (2003) · Nature Immunology · doi:10.1038/ni875 · Cited by 1,868
Interleukin-22, a TH17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis
Zheng, Y., Danilenko, D. M., Valdez, P., Kasman, I., Eastham-Anderson, J., Wu, J., & Ouyang, W. (2007) · Nature · doi:10.1038/nature05505 · Cited by 1,862
Self-citationUstekinumab as Induction and Maintenance Therapy for Crohn’s Disease
Feagan, B. G., Sandborn, W. J., Gasink, C., Jacobstein, D., Lang, Y., Friedman, J. R., Blank, M. A., Johanns, J., Gao, L.-L., Miao, Y., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1602773 · Cited by 1,845
IL28B is associated with response to chronic hepatitis C interferon-α and ribavirin therapy
Study, F. T. H. C., Suppiah, V., Moldovan, M., Ahlenstiel, G., Berg, T., Weltman, M., Abate, M. L., Bassendine, M., Spengler, U., Dore, G. J., et al. (2009) · Nature Genetics · doi:10.1038/ng.447 · Cited by 1,826
Cellular and molecular basis of wound healing in diabetes
Brem, H., & Tomic-Canic, M. (2007) · Journal of Clinical Investigation · doi:10.1172/jci32169 · Cited by 1,810
Kaser, A., Zeissig, S., & Blumberg, R. S. (2010) · Annual Review of Immunology · doi:10.1146/annurev-immunol-030409-101225 · Cited by 1,806
Hanauer, S. B., Sandborn, W. J., Rutgeerts, P., Fedorak, R. N., Lukas, M., MacIntosh, D., Panaccione, R., Wolf, D., & Pollack, P. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.11.030 · Cited by 1,715
IL-28, IL-29 and their class II cytokine receptor IL-28R
Sheppard, P., Kindsvogel, W., Xu, W., Henderson, K., Schlutsmeyer, S., Whitmore, T. E., Kuestner, R., Garrigues, U., Birks, C., Roraback, J., et al. (2003) · Nature Immunology · doi:10.1038/ni873 · Cited by 1,570
IL-23 is essential for T cell–mediated colitis and promotes inflammation via IL-17 and IL-6
Yen, D., Cheung, J., Scheerens, H., Poulet, F., McClanahan, T., Mckenzie, B., Kleinschek, M. A., Owyang, A., Mattson, J., Blumenschein, W., et al. (2006) · Journal of Clinical Investigation · doi:10.1172/jci21404 · Cited by 1,542
Treatment of Murine Colitis by Lactococcus lactis Secreting Interleukin-10
Steidler, L., Hans, W., Schotte, L., Neirynck, S., Obermeier, F., Falk, W., Fiers, W., & Remaut, E. (2000) · Science · doi:10.1126/science.289.5483.1352 · Cited by 1,513
Pathophysiology of acute wound healing
Li, J., Chen, J., & Kirsner, R. (2007) · Clinics in Dermatology · doi:10.1016/j.clindermatol.2006.09.007 · Cited by 1,486
Sellon, R. K., Tonkonogy, S., Schultz, M., Dieleman, L. A., Grenther, W., Balish, E., Rennick, D. M., & Sartor, R. B. (1998) · Infection and Immunity · doi:10.1128/iai.66.11.5224-5231.1998 · Cited by 1,483
Inflammatory Bowel Disease and Mutations Affecting the Interleukin-10 Receptor
Glocker, E.-O., Kotlarz, D., Boztug, K., Gertz, E. M., Schäffer, A. A., Noyan, F., Perro, M., Diestelhorst, J., Allroth, A., Murugan, D., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0907206 · Cited by 1,461
D'Andrea, A., Aste-Amezaga, M., Valiante, N. M., Ma, X., Kubin, M., & Trinchieri, G. (1993) · The Journal of experimental medicine · doi:10.1084/jem.178.3.1041 · Cited by 1,385
IL-22 Increases the Innate Immunity of Tissues
Wolk, K., Kunz, S., Witte, E., Friedrich, M., Asadullah, K., & Sabat, R. (2004) · Immunity · doi:10.1016/j.immuni.2004.07.007 · Cited by 1,359
Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes
Rousset, F., Garcia, E., Defrance, T., Péronne, C., Vezzio, N., Hsu, D. H., Kastelein, R., Moore, K. W., & Banchereau, J. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.5.1890 · Cited by 1,238
Certolizumab Pegol for the Treatment of Crohn's Disease
Sandborn, W. J., Feagan, B. G., Stoinov, S., Honiball, P. J., Rutgeerts, P., Mason, D., Bloomfield, R., & Schreiber, S. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa067594 · Cited by 1,143
Interleukin-22 promotes intestinal-stem-cell-mediated epithelial regeneration
Lindemans, C. A., Calafiore, M., Mertelsmann, A. M., O’Connor, M. H., Dudakov, J. A., Jenq, R. R., Velardi, E., Young, L. F., Smith, O. M., Lawrence, G., et al. (2015) · Nature · doi:10.1038/nature16460 · Cited by 1,109
I nterleukin -10 and R elated C ytokines and R eceptors
Pestka, S., Krause, C. D., Sarkar, D., Walter, M. R., Shi, Y., & Fisher, P. B. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104622 · Cited by 1,094
Järnerot, G., Hertervig, E., Friis-Liby, I., Blomquist, L., Karlén, P., Grännö, C., Vilien, M., Ström, M., Danielsson, Å., Verbaan, H., et al. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.03.003 · Cited by 1,089
Jeffcoate, W. J., & Harding, K. G. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13169-8 · Cited by 1,050
Sonnenberg, G. F., Fouser, L. A., & Artis, D. (2011) · Nature Immunology · doi:10.1038/ni.2025 · Cited by 1,044
STAT3 links IL-22 signaling in intestinal epithelial cells to mucosal wound healing
Pickert, G., Neufert, C., Leppkes, M., Zheng, Y., Wittkopf, N., Warntjen, M., Lehr, H.-A., Hirth, S., Weigmann, B., Wirtz, S., et al. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20082683 · Cited by 1,043
Self-citationIL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis
Sugimoto, K., Ogawa, A., Mizoguchi, E., Shimomura, Y., Andoh, A., Bhan, A. K., Blumberg, R. S., Xavier, R. J., & Mizoguchi, A. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33194 · Cited by 1,023
Ruffell, B., Chang-Strachan, D., Chan, V., Rosenbusch, A., Ho, C. M. T., Pryer, N., Daniel, D., Hwang, E. S., Rugo, H. S., & Coussens, L. M. (2014) · Cancer Cell · doi:10.1016/j.ccell.2014.09.006 · Cited by 1,008
Gittler, J. K., Shemer, A., Suárez-Fariñas, M., Fuentes-Duculan, J., Gulewicz, K. J., Wang, C. Q. F., Mitsui, H., Cardinale, I., de Guzman Strong, C., Krueger, J. G., et al. (2012) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.07.012 · Cited by 981
Interleukin-10 Therapy—Review of a New Approach
Asadullah, K., Sterry, W., & Volk, H. D. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.2.4 · Cited by 946
Wolk, K., Witte, E., Wallace, E., Döcke, W., Kunz, S., Asadullah, K., Volk, H., Sterry, W., & Sabat, R. (2006) · European Journal of Immunology · doi:10.1002/eji.200535503 · Cited by 922
Boniface, K., Bernard, F.-X., Garcia, M., Gurney, A. L., Lecron, J.-C., & Morel, F. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.6.3695 · Cited by 864
Innate and Adaptive Interleukin-22 Protects Mice from Inflammatory Bowel Disease
Zenewicz, L. A., Yancopoulos, G. D., Valenzuela, D. M., Murphy, A. J., Stevens, S., & Flavell, R. A. (2008) · Immunity · doi:10.1016/j.immuni.2008.11.003 · Cited by 800
Interleukin-10 induces a long-term antigen-specific anergic state in human CD4+ T cells.
Groux, H., Bigler, M., de Vries, J. E., & Roncarolo, M. G. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.1.19 · Cited by 777
Sommereyns, C., Paul, S., Staeheli, P., & Michiels, T. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.1000017 · Cited by 772
Sandborn, W. J., Feagan, B. G., Fedorak, R. N., Scherl, E., Fleisher, M. R., Katz, S., Johanns, J., Blank, M., & Rutgeerts, P. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.07.014 · Cited by 753
IL-22BP is regulated by the inflammasome and modulates tumorigenesis in the intestine
Huber, S., Gagliani, N., Zenewicz, L. A., Huber, F. J., Bosurgi, L., Hu, B., Hedl, M., Zhang, W., O’Connor, W., Murphy, A. J., et al. (2012) · Nature · doi:10.1038/nature11535 · Cited by 719
Self-citationChan, J. R., Blumenschein, W., Murphy, E., Diveu, C., Wiekowski, M., Abbondanzo, S., Lucian, L., Geissler, R., Brodie, S., Kimball, A. B., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20060244 · Cited by 680
Circulating Th17, Th22, and Th1 Cells Are Increased in Psoriasis
Kagami, S., Rizzo, H. L., Lee, J. J., Koguchi, Y., & Blauvelt, A. (2010) · Journal of Investigative Dermatology · doi:10.1038/jid.2009.399 · Cited by 640
IL-23–responsive innate lymphoid cells are increased in inflammatory bowel disease
Geremia, A., Arancibia-Cárcamo, C. V., Fleming, M. P. P., Rust, N., Singh, B., Mortensen, N. J., Travis, S. P. L., & Powrie, F. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20101712 · Cited by 640
Long-Term Survival and Late Deaths After Allogeneic Hematopoietic Cell Transplantation
Wingard, J. R., Majhail, N. S., Brazauskas, R., Wang, Z., Sobocinski, K. A., Jacobsohn, D., Sorror, M. L., Horowitz, M. M., Bolwell, B., Rizzo, J. D., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.33.7212 · Cited by 632
Zenewicz, L. A., Yancopoulos, G. D., Valenzuela, D. M., Murphy, A. J., Karow, M., & Flavell, R. A. (2007) · Immunity · doi:10.1016/j.immuni.2007.07.023 · Cited by 628
Nograles, K. E., Zaba, L. C., Shemer, A., Fuentes-Duculan, J., Cardinale, I., Kikuchi, T., Ramon, M., Bergman, R., Krueger, J. G., & Guttman-Yassky, E. (2009) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.03.041 · Cited by 627 · cited 3×
“In contrast to psoriasis, the expression of IL-22 in AD ismainly derived fromTh22 cells and from IL-22-producing CD8 cells (Nograles et al. 2009).”
BackgroundResultRadaeva, S., Sun, R., Pan, H.-N., Hong, F., & Gao, B. (2004) · Hepatology · doi:10.1002/hep.20184 · Cited by 597
Ank, N., West, H., Bartholdy, C., Eriksson, K., Thomsen, A. R., & Paludan, S. R. (2006) · Journal of Virology · doi:10.1128/jvi.80.9.4501-4509.2006 · Cited by 596
the IBSEN study group, Franke, A., Balschun, T., Karlsen, T. H., Sventoraityte, J., Nikolaus, S., Mayr, G., Domingues, F. S., Albrecht, M., Nothnagel, M., et al. (2008) · Nature Genetics · doi:10.1038/ng.221 · Cited by 591
Hanash, A. M., Dudakov, J. A., Hua, G., O’Connor, M. H., Young, L. F., Singer, N. V., West, M. L., Jenq, R. R., Holland, A. M., Kappel, L. W., et al. (2012) · Immunity · doi:10.1016/j.immuni.2012.05.028 · Cited by 584
Cutting Edge: Immune Cells as Sources and Targets of the IL-10 Family Members?
Wolk, K., Kunz, S., Asadullah, K., & Sabat, R. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.11.5397 · Cited by 583
Therapeutic opportunities of the IL-22–IL-22R1 system
Sabat, R., Ouyang, W., & Wolk, K. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4176 · Cited by 562
Self-citationMarcello, T., Grakoui, A., Barba–Spaeth, G., Machlin, E. S., Kotenko, S. V., Macdonald, M. R., & Rice, C. M. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.09.052 · Cited by 561
Blumberg, H., Conklin, D., Xu, W., Grossmann, A., Brender, T., Carollo, S., Eagan, M., Foster, D., Haldeman, B. A., Hammond, A., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00187-8 · Cited by 547
Ma, H.-L., Liang, S., Li, J., Napierata, L., Brown, T., Benoit, S., Senices, M., Gill, D., Dunussi-Joannopoulos, K., Collins, M., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33263 · Cited by 544
Steidler, L., Neirynck, S., Huyghebaert, N., Snoeck, V., Vermeire, A., Goddeeris, B., Cox, E., Remon, J. P., & Remaut, E. (2003) · Nature Biotechnology · doi:10.1038/nbt840 · Cited by 542
Xie, M.-H., Aggarwal, S., Ho, W.-H., Foster, J., Zhang, Z., Stinson, J., Wood, W. I., Goddard, A. D., & Gurney, A. L. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m005304200 · Cited by 540
Innate lymphoid cells sustain colon cancer through production of interleukin-22 in a mouse model
Kirchberger, S., Royston, D. J., Boulard, O., Thornton, E., Franchini, F., Szabady, R. L., Harrison, O., & Powrie, F. (2013) · Journal of Experimental Medicine · doi:10.1084/jem.20122308 · Cited by 529
Chronically Inflamed Human Tissues Are Infiltrated by Highly Differentiated Th17 Lymphocytes
Pène, J., Chevalier, S., Preisser, L., Vénéreau, E., Guilleux, M.-H., Ghannam, S., Molès, J.-P., Danger, Y., Ravon, E., Lesaux, S., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.11.7423 · Cited by 527
Williams, H. C. (2005) · New England Journal of Medicine · doi:10.1056/nejmcp042803 · Cited by 523
Shen, H., Goodall, J. C., & Hill Gaston, J. S. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24568 · Cited by 516
Sa, S. M., Valdez, P. A., Wu, J., Jung, K., Zhong, F., Hall, L., Kasman, I., Winer, J., Modrusan, Z., Danilenko, D. M., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.4.2229 · Cited by 514
Self-citationFedorak, R. N., Gangl, A., Elson, C. O., Rutgeerts, P., Schreiber, S., Wild, G., Hanauer, S. B., Kilian, A., Cohard, M., LeBeaut, A., et al. (2000) · Gastroenterology · doi:10.1053/gast.2000.20229 · Cited by 512
Steinbrink, K., Jonuleit, H., Müller, G., Schuler, G., Knop, J., & Enk, A. H. (1999) · Blood · doi:10.1182/blood.v93.5.1634 · Cited by 511
Cassatella, M. A., Meda, L., Bonora, S., Ceska, M., & Constantin, G. (1993) · The Journal of experimental medicine · doi:10.1084/jem.178.6.2207 · Cited by 507
Interleukin-22 alleviates metabolic disorders and restores mucosal immunity in diabetes
Wang, X., Ota, N., Manzanillo, P., Kates, L., Zavala-Solorio, J., Eidenschenk, C., Zhang, J., Lesch, J., Lee, W. P., Ross, J., et al. (2014) · Nature · doi:10.1038/nature13564 · Cited by 500
Self-citationvan Deventer, S., Elson, C., & Fedorak, R. (1997) · Gastroenterology · doi:10.1053/gast.1997.v113.pm9247454 · Cited by 486
Jiang, H., Lin, J. J., Su, Z.-Z., Goldstein, N. I., & Fisher, P. B. (1995) · PubMed · Cited by 486
Andoh, A., Zhang, Z., Inatomi, O., Fujino, S., Deguchi, Y., Araki, Y., Tsujikawa, T., Kitoh, K., Kim–Mitsuyama, S., Takayanagi, A., et al. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.06.071 · Cited by 481
The paradoxical role of IL-10 in immunity and cancer
Mannino, M. H., Zhu, Z., Xiao, H., Bai, Q., Wakefield, M. R., & Fang, Y. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.07.009 · Cited by 473
Braganza, J. M., Lee, S. H., McCloy, R. F., & McMahon, M. J. (2011) · The Lancet · doi:10.1016/s0140-6736(10)61852-1 · Cited by 469
Llorente, L., Richaud-Patin, Y., García-Padilla, C., Claret, E., Jakez-Ocampo, J., Cardiel, M. H., Alcocer-Varela, J., Grangeot-Keros, L., Alarcón-Segovia, D., Wijdenes, J., et al. (2000) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200008)43:8<1790::aid-anr15>3.0.co;2-2 · Cited by 461
Safety and efficacy of recombinant human interleukin 10 in chronic active Crohn's disease
Schreiber, S., Fedorak, R. N., Nielsen, O. H., Wild, G., Williams, C. N., Nikolaus, S., Jacyna, M., Lashner, B. A., Gangl, A., Rutgeerts, P., et al. (2000) · Gastroenterology · doi:10.1053/gast.2000.20196 · Cited by 458
Strategies for use of IL‐10 or its antagonists in human disease
O'Garra, A., Barrat, F. J., Castro, A. G., Vicari, A., & Hawrylowicz, C. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00635.x · Cited by 452
Mordstein, M., Neugebauer, E., Ditt, V., Jessen, B., Rieger, T., Falcone, V., Sorgeloos, F., Ehl, S., Mayer, D., Kochs, G., et al. (2010) · Journal of Virology · doi:10.1128/jvi.00272-10 · Cited by 443
IL‐22, not simply a Th17 cytokine
Rutz, S., Eidenschenk, C., & Ouyang, W. (2013) · Immunological Reviews · doi:10.1111/imr.12027 · Cited by 435
Self-citationKi, S. H., Park, O., Zheng, M., Morales-Ibanez, O., Kolls, J. K., Bataller, R., & Gao, B. (2010) · Hepatology · doi:10.1002/hep.23837 · Cited by 434
Chernoff, A. E., Granowitz, E. V., Shapiro, L., Vannier, E., Lonnemann, G., Angel, J. B., Kennedy, J. S., Rabson, A. R., Wolff, S. M., & Dinarello, C. A. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.10.5492 · Cited by 418
IL-10 Elicits IFNγ-Dependent Tumor Immune Surveillance
Mumm, J. B., Emmerich, J., Zhang, X., Chan, I., Wu, L., Mauze, S., Blaisdell, S., Basham, B., Dai, J., Grein, J., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.11.003 · Cited by 418
The IL-20 subfamily of cytokines — from host defence to tissue homeostasis
Rutz, S., Wang, X., & Ouyang, W. (2014) · Nature Reviews Immunology · doi:10.1038/nri3766 · Cited by 416
Self-citationAsadullah, K., Sterry, W., Stephanek, K., Jasulaitis, D., Leupold, M., Audring, H., Volk, H. D., & Döcke, W. D. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1476 · Cited by 415
Wolk, K., Haugen, H. S., Xu, W., Witte, E., Waggie, K., Anderson, M., vom Baur, E., Witte, K., Warszawska, K., Philipp, S., et al. (2009) · Journal of Molecular Medicine · doi:10.1007/s00109-009-0457-0 · Cited by 412
Expression of interleukin‐22 in rheumatoid arthritis: Potential role as a proinflammatory cytokine
Ikeuchi, H., Kuroiwa, T., Hiramatsu, N., Kaneko, Y., Hiromura, K., Ueki, K., & Nojima, Y. (2005) · Arthritis & Rheumatism · doi:10.1002/art.20965 · Cited by 399
Interleukin-22 Drives Endogenous Thymic Regeneration in Mice
Dudakov, J. A., Hanash, A. M., Jenq, R. R., Young, L. F., Ghosh, A., Singer, N. V., West, M. L., Smith, O. M., Holland, A. M., Tsai, J. J., et al. (2012) · Science · doi:10.1126/science.1218004 · Cited by 390
Interleukin‐10 inhibits B7 and intercellular adhesion molecule‐1 expression on human monocytes
Willems, F., Marchant, A., Delville, J., Gérard, C., Delvaux, A., Velu, T., De Boer, M., & Goldman, M. (1994) · European Journal of Immunology · doi:10.1002/eji.1830240435 · Cited by 376
Inhibitory and Stimulatory Effects of IL-10 on Human CD8+ T Cells
Groux, H., Bigler, M., de Vries, J. E., & Roncarolo, M.-G. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.7.3188 · Cited by 376
Viral Infections Activate Types I and III Interferon Genes through a Common Mechanism
Onoguchi, K., Yoneyama, M., Takemura, A., Akira, S., Taniguchi, T., Namiki, H., & Fujita, T. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m608618200 · Cited by 355
Guilloteau, K., Paris, I., Pedretti, N., Boniface, K., Juchaux, F., Huguier, V., Guillet, G., Bernard, F.-X., Lecron, J.-C., & Morel, F. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0902464 · Cited by 353 · cited 2×
“…cytokines can be further synergized by other proinflammatory cytokines, such as IL-17A, TNF-α, or IFN-γ (Liang et al. 2006; Tohyama et al. 2009; Guilloteau et al. 2010), suggesting that IL-20 subfamily cytokines in conjunction with other proinflammatory cytokines orchestrate the pathogenesis…”
BackgroundRegulation of neutrophil-derived chemokine expression by IL-10.
Kasama, T., Strieter, R. M., Lukacs, N. W., Burdick, M. D., & Kunkel, S. L. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.152.7.3559 · Cited by 343
Levy, Y., & Brouet, J. C. (1994) · Journal of Clinical Investigation · doi:10.1172/jci116977 · Cited by 340
Mordstein, M., Kochs, G., Dumoutier, L., Renauld, J.-C., Paludan, S. R., Klucher, K., & Staeheli, P. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.1000151 · Cited by 325
Proinflammatory Effects of IL-10 During Human Endotoxemia
Lauw, F. N., Pajkrt, D., Hack, C. E., Kurimoto, M., van Deventer, S. J. H., & van der Poll, T. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.5.2783 · Cited by 318
Saxena, A., Khosraviani, S., Noel, S., Mohan, D., Donner, T., & Hamad, A. R. A. (2015) · Cytokine · doi:10.1016/j.cyto.2014.10.031 · Cited by 306
Interleukin-22: A novel T- and NK-cell derived cytokine that regulates the biology of tissue cells
Wolk, K., & Sabat, R. (2006) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2006.09.001 · Cited by 303
Wogensen, L., Lee, M. S., & Sarvetnick, N. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.4.1379 · Cited by 294
A role for T cell-derived interleukin 22 in psoriatic skin inflammation
Boniface, K., Guignouard, E., Pedretti, N., Garcia, M., Delwail, A., Bernard, F.-X., Nau, F., Guillet, G., Dagregorio, G., Yssel, H., et al. (2007) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2007.03511.x · Cited by 290
The melanoma differentiation associated gene mda-7 suppresses cancer cell growth.
Jiang, H., Su, Z. Z., Lin, J. J., Goldstein, N. I., Young, C. S., & Fisher, P. B. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.17.9160 · Cited by 278
Sfikakis, P. P. (2010) · Current Directions in Autoimmunity · doi:10.1159/000289205 · Cited by 275
Tilg, H., van Montfrans, C., van den Ende, A., Kaser, A., van Deventer, S. J. H., Schreiber, S., Gregor, M., Ludwiczek, O., Rutgeerts, P., Gasche, C., et al. (2002) · Gut · doi:10.1136/gut.50.2.191 · Cited by 272
Emmerich, J., Mumm, J. B., Chan, I. H., LaFace, D., Truong, H., McClanahan, T., Gorman, D. M., & Oft, M. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-0721 · Cited by 270
Altered Immune Responses in Interleukin 10 Transgenic Mice
Hagenbaugh, A., Sharma, S., Dubinett, S. M., Wei, S. H.-Y., Aranda, R., Cheroutre, H., Fowell, D. J., Binder, S., Tsao, B., Locksley, R. M., et al. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.12.2101 · Cited by 269
Engelhardt, K. R., Shah, N., Faizura-Yeop, I., Kocacik Uygun, D. F., Frede, N., Muise, A. M., Shteyer, E., Filiz, S., Chee, R., Elawad, M., et al. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.09.025 · Cited by 267
Thomas, E., Gonzalez, V. D., Li, Q., Modi, A. A., Chen, W., Noureddin, M., Rotman, Y., & Liang, T. J. (2012) · Gastroenterology · doi:10.1053/j.gastro.2011.12.055 · Cited by 266
Caudell, E. G., Mumm, J. B., Poindexter, N., Ekmekcioglu, S., Mhashilkar, A. M., Yang, X. H., Retter, M. W., Hill, P., Chada, S., & Grimm, E. A. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.12.6041 · Cited by 262
IL-28 and IL-29: Newcomers to the interferon family
Uzé, G., & Monneron, D. (2007) · Biochimie · doi:10.1016/j.biochi.2007.01.008 · Cited by 260
Interferons: Success in anti-viral immunotherapy
Lin, F.-C., & Young, H. A. (2014) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2014.07.015 · Cited by 254
Su, Z.-Z., Madireddi, M. T., Lin, J. J., Young, C. S. H., Kitada, S., Reed, J. C., Goldstein, N. I., & Fisher, P. B. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.24.14400 · Cited by 254
IL-22 Deficiency Alters Colonic Microbiota To Be Transmissible and Colitogenic
Zenewicz, L. A., Yin, X., Wang, G., Elinav, E., Hao, L., Zhao, L., & Flavell, R. A. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1300016 · Cited by 250
Park, O., Wang, H., Weng, H., Feigenbaum, L., Li, H., Yin, S., Ki, S. H., Yoo, S. H., Dooley, S., Wang, F.-S., et al. (2011) · Hepatology · doi:10.1002/hep.24339 · Cited by 242
The role of IL-10 in human B cell activation, proliferation, and differentiation.
Itoh, K., & Hirohata, S. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.9.4341 · Cited by 241
Interleukin 10 (Tenovil) in the prevention of postoperative recurrence of Crohn's disease
Colombel, J.-F., Rutgeerts, P., Malchow, H., Jacyna, M., Nielsen, O. H., Rask-Madsen, J., Van Deventer, S., Ferguson, A., Desreumaux, P., Forbes, A., et al. (2001) · Gut · doi:10.1136/gut.49.1.42 · Cited by 240
Michaels, J., Churgin, S. S., Blechman, K. M., Greives, M. R., Aarabi, S., Galiano, R. D., & Gurtner, G. C. (2007) · Wound Repair and Regeneration · doi:10.1111/j.1524-475x.2007.00273.x · Cited by 227
Munneke, J. M., Björklund, A. T., Mjösberg, J. M., Garming-Legert, K., Bernink, J. H., Blom, B., Huisman, C., van Oers, M. H. J., Spits, H., Malmberg, K.-J., et al. (2014) · Blood · doi:10.1182/blood-2013-11-536888 · Cited by 225
Naing, A., Papadopoulos, K. P., Autio, K. A., Ott, P. A., Patel, M. R., Wong, D. J., Falchook, G. S., Pant, S., Whiteside, M., Rasco, D. R., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2016.68.1106 · Cited by 222
Biological activity of interleukins-28 and -29: Comparison with type I interferons
MEAGER, A., VISVALINGAM, K., DILGER, P., BRYAN, D., & WADHWA, M. (2005) · Cytokine · doi:10.1016/j.cyto.2005.04.003 · Cited by 220
Interferon induction and function at the mucosal surface
Durbin, R. K., Kotenko, S. V., & Durbin, J. E. (2013) · Immunological Reviews · doi:10.1111/imr.12101 · Cited by 220
Zhang, L., Li, Y.-G., Li, Y.-H., Qi, L., Liu, X.-G., Yuan, C.-Z., Hu, N.-W., Ma, D.-X., Li, Z.-F., Yang, Q., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031000 · Cited by 216
Survival, Physiology, and Lysis of Lactococcus lactis in the Digestive Tract
Drouault, S., Corthier, G., Ehrlich, S. D., & Renault, P. (1999) · Applied and Environmental Microbiology · doi:10.1128/aem.65.11.4881-4886.1999 · Cited by 206
Brand, S., Beigel, F., Olszak, T., Zitzmann, K., Eichhorst, S. T., Otte, J.-M., Diebold, J., Diepolder, H., Adler, B., Auernhammer, C. J., et al. (2005) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00126.2005 · Cited by 205
Tong, A. W., Nemunaitis, J., Su, D., Zhang, Y., Cunningham, C., Senzer, N., Netto, G., Rich, D., Mhashilkar, A., Parker, K., et al. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2004.09.021 · Cited by 200
Witte, K., Gruetz, G., Volk, H.-D., Looman, A. C., Asadullah, K., Sterry, W., Sabat, R., & Wolk, K. (2009) · Genes & Immunity · doi:10.1038/gene.2009.72 · Cited by 198
Broadhurst, M. J., Leung, J. M., Kashyap, V., McCune, J. M., Mahadevan, U., McKerrow, J. H., & Loke, P. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3001500 · Cited by 198
Interferon-λ Is Functionally an Interferon but Structurally Related to the Interleukin-10 Family
Gad, H. H., Dellgren, C., Hamming, O. J., Vends, S., Paludan, S. R., & Hartmann, R. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.002923 · Cited by 196
Rutz, S., Noubade, R., Eidenschenk, C., Ota, N., Zeng, W., Zheng, Y., Hackney, J., Ding, J., Singh, H., & Ouyang, W. (2011) · Nature Immunology · doi:10.1038/ni.2134 · Cited by 195
Self-citationAntitumor Activity of IFN-λ in Murine Tumor Models
Sato, A., Ohtsuki, M., Hata, M., Kobayashi, E., & Murakami, T. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.12.7686 · Cited by 195
Kamanaka, M., Huber, S., Zenewicz, L. A., Gagliani, N., Rathinam, C., O'Connor, W., Wan, Y. Y., Nakae, S., Iwakura, Y., Hao, L., et al. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20102149 · Cited by 190
HongnaPan, FengHong, SvetlanaRadaeva, & BinGao (2004) · PubMed · Cited by 188
Pan, H., Hong, F., Radaeva, S., & Gao, B. (2004) · PubMed · Cited by 186
IL-22 is related to development of human colon cancer by activation of STAT3
Jiang, R., Wang, H., Deng, L., Hou, J., Shi, R., Yao, M., Gao, Y., Yao, A., Wang, X., Yu, L., et al. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-59 · Cited by 182
Self-citationWolk, K., Witte, E., Warszawska, K., Schulze‐Tanzil, G., Witte, K., Philipp, S., Kunz, S., Döcke, W., Asadullah, K., Volk, H., et al. (2009) · European Journal of Immunology · doi:10.1002/eji.200939687 · Cited by 181
Weiss, G., Bogdan, C., & Hentze, M. W. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.1.420 · Cited by 177
IFN‐α subtypes: distinct biological activities in anti‐viral therapy
Gibbert, K., Schlaak, J., Yang, D., & Dittmer, U. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12010 · Cited by 174
Acinar Cells of the Pancreas Are a Target of Interleukin-22
Aggarwal, S., Xie, M.-H., Maruoka, M., Foster, J., & Gurney, A. L. (2001) · Journal of Interferon & Cytokine Research · doi:10.1089/107999001317205178 · Cited by 172
Lambda Interferon Inhibits Human Immunodeficiency Virus Type 1 Infection of Macrophages
Hou, W., Wang, X., Ye, L., Zhou, L., Yang, Z.-Q., Riedel, E., & Ho, W.-Z. (2009) · Journal of Virology · doi:10.1128/jvi.01773-08 · Cited by 171
Self-citationSteiniche, T., Kragballe, K., Rømer, J., Hasselager, E., Nørby, P. L., & Thorn Clausen, J. (2003) · Journal of Investigative Dermatology · doi:10.1111/j.1523-1747.2003.12626.x · Cited by 167
Schwager, K., Kaspar, M., Bootz, F., Marcolongo, R., Paresce, E., Neri, D., & Trachsel, E. (2009) · Arthritis Research & Therapy · doi:10.1186/ar2814 · Cited by 167
IL-10 fails to abrogate experimental autoimmune encephalomyelitis
Cannella, B., Gao, Y. L., Brosnan, C., & Raine, C. S. (1996) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19960915)45:6<735::aid-jnr10>3.0.co;2-v · Cited by 165
Corvaisier, M., Delneste, Y., Jeanvoine, H., Preisser, L., Blanchard, S., Garo, E., Hoppe, E., Barré, B., Audran, M., Bouvard, B., et al. (2012) · PLoS Biology · doi:10.1371/journal.pbio.1001395 · Cited by 165
Regulation of Interleukin-10 Expression
Rutz, S., & Ouyang, W. (2016) · Advances in Experimental Medicine and Biology · doi:10.1007/978-94-024-0921-5_5 · Cited by 163
Self-citationIL-22 promotes fibroblast-mediated wound repair in the skin
McGee, H. M., Schmidt, B. A., Booth, C. J., Yancopoulos, G. D., Valenzuela, D. M., Murphy, A. J., Stevens, S., Flavell, R. A., & Horsley, V. (2013) · Journal of Investigative Dermatology · doi:10.1038/jid.2012.463 · Cited by 161
IL-10 Controls Ultraviolet-Induced Carcinogenesis in Mice
Loser, K., Apelt, J., Voskort, M., Mohaupt, M., Balkow, S., Schwarz, T., Grabbe, S., & Beissert, S. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.1.365 · Cited by 160
Ota, N., Wong, K., Valdez, P. A., Zheng, Y., Crellin, N. K., Diehl, L., & Ouyang, W. (2011) · Nature Immunology · doi:10.1038/ni.2089 · Cited by 160
Self-citationFeng, D., Kong, X., Weng, H., Park, O., Wang, H., Dooley, S., Gershwin, M. E., & Gao, B. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.03.044 · Cited by 159
MDA-7/IL-24: novel cancer growth suppressing and apoptosis inducing cytokine
Sauane, M., Gopalkrishnan, R. V., Sarkar, D., Su, Z.-Z., Lebedeva, I. V., Dent, P., Pestka, S., & Fisher, P. B. (2002) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(02)00074-6 · Cited by 155
Huhn, R. D., Radwanski, E., O'Connell, S., Sturgill, M. G., Clarke, L., Cody, R., Affrime, M. B., & Cutler, D. (1996) · Blood · doi:10.1182/blood.v87.2.699.bloodjournal872699 · Cited by 154
Function of interleukin‐20 as a proinflammatory molecule in rheumatoid and experimental arthritis
Hsu, Y., Li, H. H., Hsieh, M., Liu, M.-F., Huang, K., Chin, L.-S., Chen, P., Cheng, H., & Chang, M. (2006) · Arthritis & Rheumatism · doi:10.1002/art.22039 · Cited by 146
A pathogenic role for T cell–derived IL-22BP in inflammatory bowel disease
Pelczar, P., Witkowski, M., Pérez, L. G., Kempski, J., Hammel, A., Brockmann, L., Kleinschmidt, D., Wende, S., Haueis, C., Bedke, T., et al. (2016) · Science · doi:10.1126/science.aah5903 · Cited by 146
A randomized phase 2b study of peginterferon lambda-1a for the treatment of chronic HCV infection
Muir, A. J., Arora, S., Everson, G. T., Flisiak, R., George, J., Ghalib, R. H., Gordon, S. C., Gray, T. E., Greenbloom, S., Hassanein, T., et al. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.07.022 · Cited by 145
Park, H., Serti, E., Eke, O. F., Muchmore, B., Prokunina‐Olsson, L., Capone, S., Folgori, A., & Rehermann, B. (2012) · Hepatology · doi:10.1002/hep.25897 · Cited by 143
Elevated Th22 Cells Correlated with Th17 Cells in Patients with Rheumatoid Arthritis
Zhang, L., Li, J., Liu, X., Ma, D., Hu, N., Li, Y., Li, W., Hu, Y., Yu, S., Qu, X., et al. (2011) · Journal of Clinical Immunology · doi:10.1007/s10875-011-9540-8 · Cited by 139
IL-22-producing CD4+ cells are depleted in actively inflamed colitis tissue
Leung, J. M., Davenport, M., Wolff, M. J., Wiens, K. E., Abidi, W. M., Poles, M. A., Cho, I., Ullman, T. A., Mayer, L., & Loke, P. (2013) · Mucosal Immunology · doi:10.1038/mi.2013.31 · Cited by 137
Zhuang, Y., Peng, L., Zhao, Y., Shi, Y., Mao, X., Guo, G., Chen, W., Liu, X., Zhang, J., Liu, T., et al. (2012) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-012-1241-5 · Cited by 136
Kopp, T., Lenz, P., Bello-Fernández, C., Kastelein, R. A., Kupper, T. S., & Stingl, G. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.11.5438 · Cited by 133
Zheng, X. X., Steele, A. W., Hancock, W. W., Stevens, A. C., Nickerson, P. W., Roy‐Chaudhury, P., Tian, Y., & Strom, T. B. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.9.4507 · Cited by 132
Nemunaitis, J. J., Fong, T. C., Shabe, P., Martineau, D., & Ando, D. G. (2001) · Cancer Investigation · doi:10.1081/cnv-100102550 · Cited by 131
Pharmacodynamics of subcutaneous recombinant human interleukin-10 in healthy volunteers*
Huhn, R. D., Radwanski, E., Gallo, J., Affrime, M. B., Sabo, R., Gonyo, G., Monge, A., & Cutler, D. L. (1997) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(97)90065-5 · Cited by 131
IL-28 Elicits Antitumor Responses against Murine Fibrosarcoma
Numasaki, M., Tagawa, M., Iwata, F., Suzuki, T., Nakamura, A., Okada, M., Iwakura, Y., Aiba, S., & Yamaya, M. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.8.5086 · Cited by 127
Antitumor activity of Type I and Type III interferons in BNL hepatoma model
Abushahba, W., Balan, M., Castaneda, I., Yuan, Y., Reuhl, K. R., Raveche, E. S., de la Torre, A., Lasfar, A., & Kotenko, S. V. (2010) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-010-0831-3 · Cited by 122
Creery, W. D., Díaz‐Mitoma, F., Filion, L. G., et al. (1996) · European Journal of Immunology · doi:10.1002/eji.1830260614 · Cited by 118
Distinct roles of IL-22 in human psoriasis and inflammatory bowel disease
Ouyang, W. (2010) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2010.10.007 · Cited by 118
Self-citationKragstrup, T. W., Otkjær, K., Holm, C. K., Jørgensen, A., Hokland, M., Iversen, L., & Deleuran, B. W. (2007) · Cytokine · doi:10.1016/j.cyto.2007.10.004 · Cited by 117
Benbouziane, B., Ribelles, P., Aubry, C., Martín, R., Kharrat, P., Riazi, A., Langella, P., & Bermúdez‐Humarán, L. G. (2013) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2013.04.019 · Cited by 115
Novel interferon-λs induce antiproliferative effects in neuroendocrine tumor cells
Zitzmann, K., Brand, S., Baehs, S., Göke, B., Meinecke, J., Spöttl, G., Meyer, H. H. H. D., & Auernhammer, C. J. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.04.043 · Cited by 114
Interleukin‐10 in viral diseases and cancer: exiting the labyrinth?
Vicari, A. P., & Trinchieri, G. (2004) · Immunological Reviews · doi:10.1111/j.0105-2896.2004.00216.x · Cited by 112
Interleukin 22 serum levels are associated with radiographic progression in rheumatoid arthritis
Leipe, J., Schramm, M. A., Grünke, M., Baeuerle, M., Dechant, C., Nigg, A. P., Witt, M., Vielhauer, V., Reindl, C., Schulze‐Koops, H., et al. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2011.152074 · Cited by 112
Rousset, F., Peyrol, S., Garcia, E., Vezzio, N., Andujar, M. B., Grimaud, J.-A., & Banchereau, J. (1995) · International Immunology · doi:10.1093/intimm/7.8.1243 · Cited by 112
Otkjær, K., Kragballe, K., Funding, A. T., Clausen, J. T., Nørby, P. L., Steiniche, T., & Iversen, L. (2005) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2005.06800.x · Cited by 111
Schütze, N., Schoeneberger, S., Müller, U., Freudenberg, M. A., Alber, G., & Straubinger, R. K. (2005) · International Immunology · doi:10.1093/intimm/dxh247 · Cited by 109
Feng, D., Park, O., Radaeva, S., Wang, H., Yin, S., Kong, X., Zheng, M., Zakhari, S., Kolls, J. K., & Gao, B. (2012) · International Journal of Biological Sciences · doi:10.7150/ijbs.3967 · Cited by 109
Tohyama, M., Hanakawa, Y., Shirakata, Y., Dai, X., Yang, L., Hirakawa, S., Tokumaru, S., Okazaki, H., Sayama, K., & Hashimoto, K. (2009) · European Journal of Immunology · doi:10.1002/eji.200939473 · Cited by 105
Burkart, C., Arimoto, K., Tang, T., Cong, X., Xiao, N., Liu, Y., Kotenko, S. V., Ellies, L. G., & Zhang, D. (2013) · EMBO Molecular Medicine · doi:10.1002/emmm.201201864 · Cited by 105
Innocentin, S., Guimarães, V., Miyoshi, A., Azevedo, V., Langella, P., Chatel, J., & Lefèvre, F. (2009) · Applied and Environmental Microbiology · doi:10.1128/aem.00825-09 · Cited by 105
Regulation of apoptosis by type III interferons
Li, W., Lewis-Antes, A., Huang, J., Balan, M., & Kotenko, S. V. (2008) · Cell Proliferation · doi:10.1111/j.1365-2184.2008.00558.x · Cited by 101
Interleukin-22 Promotes Wound Repair in Diabetes by Improving Keratinocyte Pro-Healing Functions
Avitabile, S., Odorisio, T., Madonna, S., Eyerich, S., Guerra, L., Eyerich, K., Zambruno, G., Cavani, A., & Cianfarani, F. (2015) · Journal of Investigative Dermatology · doi:10.1038/jid.2015.278 · Cited by 100
Cited by
Biology and therapeutic potential of interleukin-10
Saraiva, M., Vieira, P., & O’Garra, A. (2020) · Journal of Experimental Medicine · doi:10.1084/jem.20190418 · Cited by 1,118
IL-10 Family Cytokines IL-10 and IL-22: from Basic Science to Clinical Translation
Ouyang, W., & O’Garra, A. (2019) · Immunity · doi:10.1016/j.immuni.2019.03.020 · Cited by 1,072
Self-citationHost–microbiota interactions in inflammatory bowel disease
Caruso, R., Lo, B. C., & Núñez, G. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-019-0268-7 · Cited by 780
Immunosuppressive cells in cancer: mechanisms and potential therapeutic targets
Tie, Y., Tang, F., Wei, Y.-Q., & Wei, X.-W. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01282-8 · Cited by 591
The role of IL-22 in intestinal health and disease
Keir, M. E., Yi, T., Lu, T. T., & Ghilardi, N. (2020) · Journal of Experimental Medicine · doi:10.1084/jem.20192195 · Cited by 464
Metadata
- Authors
- Wang, X., Wong, K., Ouyang, W., & Rutz, S.
- Venue
- Cold Spring Harbor Perspectives in Biology
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2017-10-16
- Volume
- 11
- Issue
- 2
- Pages
- a028548
- ISSN
- 1943-0264 (ISSN-L)
- OpenAlex
- W2765414700
- Cited by
- 302
- References
- 253
- Type
- posted content
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.